Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jul. 31, 2017	Jul. 31, 2016
Operating activities:
Net loss	$ (3,140,573)	$ (2,211,909)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	403,090	630,706
Amortization of capitalized software development costs	1,143,624	1,425,962
Amortization of intangible assets	666,114	650,892
Amortization of other deferred costs	161,064	115,113
Valuation adjustment for warrants liability	(45,831)	(61,856)
Share-based compensation expense	555,229	909,411
Other valuation adjustments	86,192	83,937
(Gain) loss on disposal of property and equipment	(720)	567
Provision for accounts receivable	166,170	88,472
Changes in assets and liabilities, net of effects of acquisitions:
Accounts and contract receivables	99,086	357,774
Other assets	(333,401)	(214,327)
Accounts payable	449,929	(403,600)
Accrued expenses	(352,132)	(472,420)
Deferred revenues	(822,867)	(759,411)
Net cash (used in) provided by operating activities	(965,026)	139,311
Investing activities:
Purchases of property and equipment	(9,812)	(60,518)
Capitalization of software development costs	(844,448)	(936,560)
Net cash used in investing activities	(854,260)	(997,078)
Financing activities:
Principal repayments on term loan	(813,197)	(2,075,172)
Principal payments on capital lease obligation	(68,149)	(438,962)
Proceeds from exercise of stock options and stock purchase plan	0	14,793
Payments related to settlement of employee shared-based awards	(37,002)	(11,702)
Net cash used in financing activities	(918,348)	(2,511,043)
Net decrease in cash and cash equivalents	(2,737,634)	(3,368,810)
Cash and cash equivalents at beginning of period	5,654,093	9,882,136
Cash and cash equivalents at end of period	$ 2,916,459	$ 6,513,326